Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Viewpoint

Vol. 153 No. 12 (2023)

Healthcare access and health equity: intricate challenges for rare diseases

  • Susanne Wehrli
  • Sebastian Wäscher
DOI
https://doi.org/10.57187/s.3644
Cite this as:
Swiss Med Wkly. 2023;153:3644
Published
02.12.2023

Summary

No abstract available.

References

  1. Nguengang Wakap S, Lambert DM, Olry A, Rodwell C, Gueydan C, Lanneau V, et al. Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database. Eur J Hum Genet. 2020 Feb;28(2):165–73. 10.1038/s41431-019-0508-0 DOI: https://doi.org/10.1038/s41431-019-0508-0
  2. von der Lippe C, Diesen PS, Feragen KB. Living with a rare disorder: a systematic review of the qualitative literature. Mol Genet Genomic Med. 2017 Nov;5(6):758–73. 10.1002/mgg3.315 DOI: https://doi.org/10.1002/mgg3.315
  3. World Health Organization. Health equity. https://www.who.int/health-topics/health-equity#tab=tab_1)
  4. Gaviglio AM, Skinner MW, Lou LJ, Finkel RS, Augustine EF, Goldenberg AJ. Gene-targeted therapies: towards equitable development, diagnosis, and access. Am J Med Genet C Semin Med Genet. 2023 Mar;193(1):56–63. 10.1002/ajmg.c.32032 DOI: https://doi.org/10.1002/ajmg.c.32032
  5. Farooq F, Mogayzel PJ, Lanzkron S, Haywood C, Strouse JJ. Comparison of US Federal and Foundation Funding of Research for Sickle Cell Disease and Cystic Fibrosis and Factors Associated With Research Productivity. JAMA Netw Open. 2020 Mar;3(3):e201737. 10.1001/jamanetworkopen.2020.1737 DOI: https://doi.org/10.1001/jamanetworkopen.2020.1737
  6. World Health Organization. Universal health coverage (UHC). https://www.who.int/news-room/fact-sheets/detail/universal-health-coverage-(uhc)
  7. Ricketts TC, Goldsmith LJ. Access in health services research: the battle of the frameworks. Nurs Outlook. 2005;53(6):274–80. 10.1016/j.outlook.2005.06.007 DOI: https://doi.org/10.1016/j.outlook.2005.06.007
  8. Souliotis K, Hasardzhiev S, Agapidaki E. A Conceptual Framework of Mapping Access to Health Care across EU Countries: The Patient Access Initiative. Public Health Genomics. 2016;19(3):153–9. 10.1159/000446533 DOI: https://doi.org/10.1159/000446533
  9. Quinn M, Robinson C, Forman J, Krein SL, Rosland AM. Survey Instruments to Assess Patient Experiences With Access and Coordination Across Health Care Settings: Available and Needed Measures. Med Care. 2017 Jul;55(Suppl 7 1 Suppl 7 Suppl 1):S84–91. 10.1097/MLR.0000000000000730 DOI: https://doi.org/10.1097/MLR.0000000000000730
  10. Levesque JF, Harris MF, Russell G. Patient-centred access to health care: conceptualising access at the interface of health systems and populations. Int J Equity Health. 2013 Mar;12(1):18. 10.1186/1475-9276-12-18 DOI: https://doi.org/10.1186/1475-9276-12-18
  11. Sequeira AR, Mentzakis E, Archangelidi O, Paolucci F. The economic and health impact of rare diseases: A meta-analysis. Health Policy Technol. 2021;10(1):32–44. 10.1016/j.hlpt.2021.02.002 DOI: https://doi.org/10.1016/j.hlpt.2021.02.002
  12. Halley MC, Halverson CM, Tabor HK, Goldenberg AJ. Rare Disease, Advocacy and Justice: Intersecting Disparities in Research and Clinical Care. Am J Bioeth. 2023 Jul;23(7):17–26. 10.1080/15265161.2023.2207500 DOI: https://doi.org/10.1080/15265161.2023.2207500
  13. Werner A, Malterud K. It is hard work behaving as a credible patient: encounters between women with chronic pain and their doctors. Soc Sci Med. 2003 Oct;57(8):1409–19. 10.1016/s0277-9536(02)00520-8 10.1016/S0277-9536(02)00520-8 DOI: https://doi.org/10.1016/S0277-9536(02)00520-8
  14. Farmer P. Pathologies of Power: Health, Human Rights, and the New War on the Poor. University of California Press; 2005.